Clinical Trial Update: Optimization of Vonoprazan--amoxicillin Dual Therapy for Eradicating Helicobacter Pyloriinfection [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating optimization of vonoprazan–amoxicillin dual therapy for Helicobacter pylori eradication has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Eradication
• Helicobacter Pylori Infection

Drugs mentioned

• vonoprazan–amoxicillin dual therapy

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Helicobacter Pylori Eradication Rate | Phase 3 | Status: COMPLETED